Niva Bupa (NIVABUPA) Q2 FY27 Profit Jumps 124% on Retail Surge, But Margins Face Pressure
The standalone health insurer posted a 124% YoY profit jump driven by a 47% surge in retail premiums, but sequential margin compression and a high base loom.
Niva Bupa's Q2 FY27 profit surged to ₹136 crore, powered by a 47% jump in retail health premiums. However, margins contracted sequentially as expenses grew, and the company faces a high base effect in the coming quarters.
For Niva Bupa, the story of the September quarter is a powerful retail engine driving profit growth, even as the road ahead gets bumpier. The standalone health insurer delivered a 124% year-on-year profit jump, a headline that masks a more nuanced picture of margin pressure and a looming high base.
The numbers show a business accelerating. Revenue grew 62% year-on-year to ₹2,572 crore. Profit after tax reached ₹136 crore, a sharp turnaround from a loss of ₹35 crore in the same quarter last year. Sequentially, however, the net profit margin slipped 30 basis points to 5.3%.
Revenue & profit
Revenue (₹ Cr)
Profit (₹ Cr)
Revenue (₹ Cr), Q2 FY26: 1,592.0
Revenue (₹ Cr), Q3 FY26: 1,617.6
Revenue (₹ Cr), Q4 FY26: 2,114.5
Revenue (₹ Cr), Q1 FY27: 2,471.8
Revenue (₹ Cr), Q2 FY27: 2,572.0
Profit (₹ Cr), Q2 FY26: -35.3
Profit (₹ Cr), Q3 FY26: -87.6
Profit (₹ Cr), Q4 FY26: 345.1
Profit (₹ Cr), Q1 FY27: 137.8
Profit (₹ Cr), Q2 FY27: 136.0
Revenue (₹ Cr)
Revenue (₹ Cr), Q2 FY26: 1,592.0
Revenue (₹ Cr), Q3 FY26: 1,617.6
Revenue (₹ Cr), Q4 FY26: 2,114.5
Revenue (₹ Cr), Q1 FY27: 2,471.8
Revenue (₹ Cr), Q2 FY27: 2,572.0
Profit (₹ Cr)
Profit (₹ Cr), Q2 FY26: -35.3
Profit (₹ Cr), Q3 FY26: -87.6
Profit (₹ Cr), Q4 FY26: 345.1
Profit (₹ Cr), Q1 FY27: 137.8
Profit (₹ Cr), Q2 FY27: 136.0
Metric
CurrentQ2 FY27
PreviousQ1 FY27
Same quarter LYQ2 FY26
Revenue (₹ Cr)
2,572.0YoY +62%
2,471.8
1,592.0
Profit (₹ Cr)
136.0YoY +485%
137.8
-35.3
PAT Margin (%)
5.3YoY +341%
5.6
-2.2
Retail Takes the Wheel
The profit surge was fueled almost entirely by the retail health segment. According to The Economic Times, retail health premiums soared 47% to ₹1,876 crore, while group business remained flat as management avoided unprofitable pricing. This retail focus improved the claims ratio to 63.1% from 65.1% a year ago, as reported by Kotak Neo.
Management, on the earnings call, indicated the retail book now makes up 77% of the business. The shift towards higher-quality, higher-sum-insured retail policies is a deliberate move to build a more sustainable and profitable franchise.
The Cost of Growth
Despite the top-line momentum, profitability faced headwinds. Total expenses grew 47% year-on-year, slightly outpacing revenue growth. The expense ratio, while improving annually, remains a key watchpoint. Furthermore, other income fell over 100% both year-on-year and sequentially, turning negative this quarter.
Live Chart
· NIVABUPA
(BSE)
ISIN: INE995S01015
This sharp decline, from ₹198 crore in Q1 to -₹2 crore in Q2, stripped away a significant earnings buffer. It highlights that the core insurance performance, while strong, is now carrying the full weight of profitability without investment income support.
Navigating a Higher Base
The immediate challenge is a tough comparison period. Nomura noted in its report that the broader retail health insurance industry, including Niva Bupa, now faces a high base from October 2026. Management has guided for continued 30% year-on-year retail growth despite this, a test of its execution and pricing discipline.
The solvency ratio, a measure of capital adequacy, declined to 2.03x from 2.85x a year ago, as rapid business growth consumes capital. The company has board approval to raise up to ₹500 crore in debt to support its plans, as mentioned in its H1 presentation.
Key Points
Retail health premiums surged 47% year-on-year, driving a 124% jump in net profit to ₹136 crore.
Core underwriting improved, with the claims ratio falling to 63.1%, but the net profit margin dipped 30 bps sequentially.
Other income turned negative, removing a prior earnings cushion and putting full focus on insurance operations.
The company faces a high base effect and a declining solvency ratio as it funds rapid growth.
“
Hexa Perspective
Niva Bupa’s quarter confirms its successful pivot to retail, a segment with better pricing power and growth visibility in India’s underpenetrated market. The improvement in claims ratio is a positive signal of underwriting discipline.
The squeeze comes from two sides: the loss of other income and the capital intensity of growth. Sustaining 30% retail expansion against a high base while managing the expense ratio and solvency will determine if this profit trajectory is durable. The market’s 6.6% stock jump on results day, noted by Kotak Neo, reflects approval of the growth story, but the margin compression is a note of caution for the quarters ahead.
Talk to a HexaWealth advisor, or sync your mutual fund data for insights tailored to your holdings.
Frequently asked questions
What were Niva Bupa's Q2 FY27 results?
For the quarter ended September 2026, Niva Bupa reported a revenue of ₹2,572 crore, a 62% increase year-on-year. Net profit stood at ₹136 crore, a significant jump from a loss of ₹35 crore in Q2 FY26, driven by strong retail premium growth.
What was Niva Bupa's net profit in Q2 FY27?
Niva Bupa's net profit for the September 2026 quarter (Q2 FY27) was ₹136 crore. This represents a 124% increase compared to the profit of ₹60 crore reported for the same quarter last year by outlets like The Economic Times.
What was Niva Bupa's revenue in Q2 FY27?
Niva Bupa's total revenue for Q2 FY27, the quarter ended September 2026, was ₹2,572 crore. This marks a substantial 61.6% growth over the ₹1,592 crore reported in the year-ago quarter.
Why did Niva Bupa's profit jump 124% in Q2 FY27?
Niva Bupa's 124% profit jump was primarily driven by a 47% surge in retail health insurance premiums, as reported by The Economic Times. Improved underwriting, with the claims ratio falling to 63.1%, also contributed to the strong bottom-line performance.
What caused the decline in Niva Bupa's other income in Q2 FY27?
Niva Bupa's other income turned negative, declining over 100% both year-on-year and quarter-on-quarter to -₹2 crore. This removed a significant earnings buffer seen in prior periods, shifting full profitability reliance to core insurance operations.
What was Niva Bupa's gross written premium in Q2 FY27?
Niva Bupa's gross written premium for Q2 FY27 was ₹2,484 crore, according to The Economic Times. This represents a 35% year-on-year growth, led by a 47% increase in retail health premiums to ₹1,876 crore.
What is Niva Bupa's solvency ratio as of Q2 FY27?
As of September 30, 2026, Niva Bupa's solvency ratio stood at 2.03 times the regulatory minimum, as per its earnings call. This is down from 2.85 times a year ago, reflecting capital consumption due to rapid business growth.
Did Niva Bupa's Q2 results beat analyst estimates?
Yes, according to Nomura, Niva Bupa's core insurance service result beat its estimate by 56%, and net profit was 53% ahead. The combined insurance service ratio of 98.8% also beat the brokerage's forecast by 297 basis points.
What is the outlook for Niva Bupa's retail growth?
Management has highlighted that retail growth continues at a 30% year-on-year pace despite a high base from October 2026. Brokerage Nomura continues to build in 23-25% annual gross premium growth for the company over FY27-28.
What was Niva Bupa's claims ratio in Q2 FY27?
Niva Bupa's claims ratio for Q2 FY27 improved to 63.09%, down from 65.08% in the year-ago quarter, as reported by Kotak Neo. This improvement in claims experience was a key driver of the quarter's profitability.
Niva Bupa Q2 YoY profit after tax soars 124%
Niva Bupa's profit after tax for Q2 FY27 (September 2026 quarter) soared 124% year-on-year to ₹136 crore, up from ₹60 crore last year. This surge was driven by a 47% jump in retail health premiums and an improved claims ratio.
Niva Bupa Q2FY27 Results: Net Profit Jumps 124% to ₹ ...
Niva Bupa's Q2 FY27 results showed net profit jumping 124% year-on-year to ₹135.64 crore, as per Kotak Neo. The company's combined operating ratio improved to 93.20%, indicating stronger core underwriting performance alongside the premium growth.